or
forgot password
  • cancer clinical trials in fort wayne, IN

  • Tivantinib in Treating Patients With Metastatic Prostate Cancer
    Fort Wayne Medical Oncology and Hematology Inc - State Boulevard
    Fort Wayne, Indiana 46845
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Fort Wayne Medical Oncology and Hematology Inc - State Boulevard
    Fort Wayne, Indiana 46845
    Breast Cancer
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Fort Wayne Medical Oncology and Hematology Inc - State Boulevard
    Fort Wayne, Indiana 46845
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery
    Fort Wayne Medical Oncology and Hematology Inc - State Boulevard
    Fort Wayne, Indiana 46845
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    Radiation Oncology Associates PC
    Fort Wayne, Indiana 46804
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
    Fort Wayne Medical Oncology and Hematology Inc - State Boulevard
    Fort Wayne, Indiana 46845
    Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma, Stage II Malignant Mesothelioma, Stage III Malignant Mesothelioma, Stage IV Malignant Mesothelioma
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Lymphoma
    Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Esophageal Cancer, Gastric Cancer
    Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer
    Docetaxel in Treating Patients With Solid Tumors
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Bladder Cancer, Breast Cancer, Head and Neck Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Leukemia
    Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer
    Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lymphoma
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer
    Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Esophageal Cancer, Gastric Cancer
    Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Head and Neck Cancer
    O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Sarcoma
    Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Bladder Cancer
    Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Anxiety Disorder, Depression, Fatigue, Lung Cancer
    O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Melanoma (Skin)
    SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer
    SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Prostate Cancer
    SU5416 in Treating Patients With Malignant Mesothelioma
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Malignant Mesothelioma
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lymphoma
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lymphoma
    Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Leukemia
    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Pancreatic Cancer
    ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Head and Neck Cancer
    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lymphoma
    CCI-779 in Treating Patients With Metastatic Melanoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Melanoma (Skin)
    BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer
    PS-341 in Treating Patients With Metastatic Kidney Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Kidney Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Pancreatic Cancer
    Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
    Fort Wayne Medical Oncology and Hematology, Inc.
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Northeast Indiana Research
    Fort Wayne, Indiana 46804-4128
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lymphoma
    Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer, Neoplasm Metastasis
    Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Head and Neck Cancer
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Fort Wayne Medical Oncology and Hematology
    Fort Wayne, Indiana 46815
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Colorectal Cancer, Diarrhea, Neutropenia
    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Prostate Cancer
    Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Pancreatic Cancer
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Malignant Mesothelioma
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Fort Wayne Medical Oncology & Hematology, Inc.
    Fort Wayne, Indiana 46815
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Northeast Indiana Research
    Fort Wayne, Indiana 46804-4128
    Prostatic Neoplasms
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Parkview Regional Cancer Center at Parkview Health
    Fort Wayne, Indiana 46805
    Lung Cancer
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Fort Wayne Medical Oncology and Hematology
    Fort Wayne, Indiana 46815
    Pancreatic Cancer
    Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Head and Neck Cancer
    Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
    Fort Wayne Medical Oncology and Hematology
    Fort Wayne, Indiana 46815
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Lung Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Fort Wayne Medical Oncology and Hematology, Incorporated
    Fort Wayne, Indiana 46885-5099
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Fort Wayne Medical Oncology and Hematology
    Fort Wayne, Indiana 46815
    Pancreatic Cancer
    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
    Fort Wayne Medical Oncology/Hematology Inc.
    Fort Wayne, Indiana 46815
    Prostate Cancer
    Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
    Fort Wayne Medical Oncology/Hem
    Fort Wayne, Indiana 46815
    Pancreatic Cancer
    Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
    Northeast Indiana Research, LLC
    Fort Wayne, Indiana 46825-1675
    Prostate Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Fort Wayne Medical Oncology and Hematology
    Fort Wayne, Indiana 46815
    Breast Cancer
    Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
    Northeast Indiana Research
    Fort Wayne, Indiana 46804-4128
    Prostate Cancer
    PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
    Fort Wayne Oncology & Hematology, Inc
    Fort Wayne, Indiana 46815
    Breast Cancer